Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03496766
Title Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Spanish Lung Cancer Group
Age Groups: adult | child | senior
Covered Countries ESP

Additional content available in CKB BOOST